Abstract
Cancer-associated DNA hypomethylation is as prevalent as cancer-linked hypermethylation, but these two types of epigenetic abnormalities usually seem to affect different DNA sequences. Much more of the genome is generally subject to undermethylation rather than overmethylation. Genomic hypermethylation in cancer has been observed most often in CpG islands in gene regions. In contrast, very frequent hypomethylation is seen in both highly and moderately repeated DNA sequences in cancer, including heterochromatic DNA repeats, dispersed retrotransposons, and endogenous retroviral elements. Also, unique sequences, including transcription control sequences, are often subject to cancer-associated undermethylation. The high frequency of cancer-linked DNA hypomethylation, the nature of the affected sequences, and the absence of associations with DNA hypermethylation are consistent with an independent role for DNA undermethylation in cancer formation or tumor progression. Increased karyotypic instability and activation of tumor-promoting genes by cis or trans effects, that might include altered heterochromatin-euchromatin interactions, may be important consequences of DNA hypomethylation which favor oncogenesis. The relationship of DNA hypomethylation to tumorigenesis is important to be considered in the light of cancer therapies involving decreasing DNA methylation. Inducing DNA hypomethylation may have short-term anticancer effects, but might also help speed tumor progression from cancer cells surviving the DNA demethylation chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baylin SB, Herman JG . 2000 DNA Alterations in Cancer: Genetic and Epigenetic Alterations Ehrlich M (ed) Natick: Eaton Publishing pp. 293–309
Bedford MT, van Helden PD . 1987 Cancer Res. 47: 5274–5276
Bernardino J, Roux C, Almeida A, Vogt N, Gibaud A, Gerbault-Seureau M, Magdelenat H, Bourgeois CA, Malfoy B, Dutrillaux B . 1997 Cancer Genet. Cytogenet. 97: 83–89
Brito-Babapulle V, Atkin NB . 1981 Cancer Genet. Cytogenet. 4: 215–225
Carr BI, Reilly G, Smith SS, Winberg C, Riggs A . 1984 Carcinogenesis 5: 1583–1590
Casau AE, Vaughan JE, Lozano G, Levine AJ . 1999 J. Virol. 73: 9976–9983
Chan MF, van Amerongen R, Nijjar T, Cuppen E, Jones PA, Laird PW . 2001 Mol. Cell. Biol. 21: 7587–7600
Chapman V, Forrester L, Sanford J, Hastie N, Rossant J . 1984 Nature 307: 284–286
Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R . 1998 Nature 395: 89–93
Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L . 1997 Br. J. Cancer 75: 396–402
Cho M, Uemura H, Kim SC, Kawada Y, Yoshida K, Hirao Y, Konishi N, Saga S, Yoshikawa K . 2001 Br. J. Cancer 85: 563–567
Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST . 2000 Genes Dev. 14: 2146–2160
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nat. Genet. 24: 132–138
Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, Feinberg AP . 2001 Cancer Res. 61: 4947–4950
Dai Z, Lakshmanan RR, Zhu WG, Smiralia DJ, Rush LJ, Fruhwald MC, Brena RM, Li B, Wright FA, Ross P, Otterson GA, Plass C . 2001 Neoplasia 3: 314–323
Dante R, Dante-Paire J, Rigal D, Roizes G . 1992 Anticancer Res. 12: 559–563
De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P . 1999 Cancer Res. 59: 3157–3165
De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T . 1996 Proc. Natl. Acad. Sci. USA 93: 7149–7153
Denda A, Rao PM, Rajalakshmi S, Sarma DS . 1985 Carcinogenesis 6: 145–146
Dupressoir A, Heidmann T . 1997 Oncogene 14: 2951–2958
Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW . 2000 Nucleic Acids Res. 28: E32
Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW . 2001 Cancer Res. 61: 3410–3418
Ehrlich M . 2000 DNA Alterations in Cancer: Genetic and Epigenetic Changes Ehrlich M (ed) BioTechniques Books Natick: Eaton Publishing pp. 273–291
Ehrlich M, Buchanan K, Tsien F, Jiang G, Sun B, Uicker W, Weemaes C, Smeets D, Sperling K, Belohradsky B, Tommerup N, Misek D, Rouillard J-M, Kuick R, Hanash S . 2001 Hum. Mol. Genet. 10: 2917–2931
Ehrlich M, Gama-Sosa M, Huang L-H, Midgett RM, Kuo KC, McCune RA, Gehrke C . 1982 Nucleic Acids Res. 10: 2709–2721
Epstein ND, Karlsson S, O'Brien S, Modi W, Moulton A, Nienhuis AW . 1987 Nucleic Acids Res. 15: 2327–2341
Esteller M, Corn PG, Baylin SB, Herman JG . 2001 Cancer Res. 61: 3225–3229
Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M . 1988 Cancer Res. 48: 1159–1161
Feinberg AP, Vogelstein B . 1983a Nature 301: 89–92
Feinberg AP, Vogelstein B . 1983b Biochem. Biophys. Res. Commun. 111: 47–54
Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA . 1999 Br. J. Cancer 80: 1312–1321
Francastel C, Magis W, Groudine M . 2001 Proc. Natl. Acad. Sci. USA 98: 12120–12125
Gama-Sosa MA, Midgett RM, Slagel VA, Githens S, Kuo KC, Gehrke CW, Ehrlich M . 1983a Biochim. Biophys. Acta 740: 212–219
Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M . 1983b Nucleic Acids Res. 11: 6883–6894
Garrick D, Fiering S, Martin D, Whitelaw E . 1998 Nat. Genet. 18: 56–59
Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP . 1985 Science 228: 187–190
Gotzinger N, Sauter M, Roemer K, Mueller-Lantzsch N . 1996 J. Gen. Virol. 77: 2983–2990
Gutekunst KA, Kashanchi F, Brady JN, Bednarik DP . 1993 J. Acquir. Immune Defic. Syndr. 6: 541–549
Hakkarainen M, Wahlfors J, Myohanen S, Hiltunen MO, Eskelinen M, Johansson R, Janne J . 1996 Int. J. Cancer 69: 471–474
Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM . 1999 Proc. Natl. Acad. Sci. USA 96: 14412–14417
Herbst H, Sauter M, Mueller-Lantzsch N . 1996 Am. J. Pathol. 149: 1727–1735
Hernandez R, Frady A, Zhang X-Y, Varela M, Ehrlich M . 1997 Cytogenet. Cell. Genet. 76: 196–201
Ishihara K, Hatano N, Furuumi H, Kato R, Iwaki T, Miura K, Jinno Y, Sasaki H . 2000 Genome Res. 10: 664–671
Issa JP . 2000 DNA Alterations in Cancer: Genetic and Epigenetic Alterations Ehrlich M (ed) Natick: Eaton Publishing pp. 311–322
Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK, Mao L . 2001 Cancer Res. 61: 7959–7963
Jeanpierre M, Turleau C, Aurias A, Prieur M, Ledeist F, Fischer A, Viegas-Pequignot E . 1993 Hum. Mol. Genet. 2: 731–735
Ji W, Hernandez R, Zhang X-Y, Qu G, Frady A, Varela M, Ehrlich M . 1997 Mutat. Res. 379: 33–41
Jurgens B, Schmitz-Drager BJ, Schulz WA . 1996 Cancer Res. 56: 5698–5703
Kazazian Jr HH, Moran JV . 1998 Nat. Genet. 19: 19–24
Kim Y-I, Giuliano A, Hatch KD, Schneider A, Nour MA, Dallal GE, Selhub J, Mason JB . 1994 Cancer 74: 893–899
Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T . 1995 Oncogene 10: 1193–1198
Kondo T, Comenge Y, Bobek MP, Kuick R, Lamb B, Zhu X, Narayan A, Bourc'his D, Viegas-Pequinot E, Ehrlich M, Hanash S . 2000 Hum. Mol. Gen. 9: 597–604
Lapeyre JN, Becker FF . 1979 Biochem. Biophys. Res. Commun. 87: 698–705
Le Baccon P, Leroux D, Dascalescu C, Duley S, Marais D, Esmenjaud E, Sotto JJ, Callanan M . 2001 Genes Chrom. Cancer 32: 250–264
Leib-Mosch C, Haltmeier M, Werner T, Geigl EM, Brack-Werner R, Francke U, Erfle V, Hehlmann R . 1993 Genomics 18: 261–269
Lethe B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, Boon T . 1998 Int. J. Cancer 76: 903–908
Li E, Beard C, Jaenisch R . 1993 Nature 366: 362–365
Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF . 2001 Cancer Res. 61: 4238–4243
Lu LJ, Randerath E, Randerath K . 1983 Cancer Lett. 19: 231–239
Malik K, Brown KW . 2000 Br. J. Cancer 83: 1583–1588
Malik K, Salpekar A, Hancock A, Moorwood K, Jackson S, Charles A, Brown KW . 2000 Cancer Res. 60: 2356–2360
Martin V, Ribieras S, Song-Wang XG, Lasne Y, Frappart L, Rio MC, Dante R . 1997 J. Cell. Biochem. 65: 95–106
Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y . 1992 Cancer Res. 52: 643–645
Mikovits JA, Raziuddin Gonda M, Ruta M, Lohrey NC, Kung HF, Ruscetti FW . 1990 J. Exp. Med. 171: 1705–1720
Miniou P, Jeanpierre M, Bourc'his D, Coutinho Barbosa AC, Blanquet V, Viegas-Pequignot E . 1997 Hum. Genet. 99: 738–745
Mitelman F, Johansson B, Mertens F . 2001 http://cgap.nci.nih.gov/Chromosomes/Mitelman
Morgan HD, Sutherland HG, Martin DI, Whitelaw E . 1999 Nat. Genet. 23: 314–318
Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM . 1988 Nature 333: 87–90
Nagai H, Baba M, Konishi N, Kim YS, Nogami M, Okumura K, Emi M, Matsubara K . 1999 DNA Res. 6: 219–225
Narayan A, Ji W, Zhang X-Y, Marrogi A, Graff JR, Baylin SB, Ehrlich M . 1998 Int. J. Cancer 77: 833–838
Nguyen C, Liang G, Nguyen TT, Tsao-Wei D, Groshen S, Lubbert M, Zhou JH, Benedict WF, Jones PA . 2001a J. Natl. Cancer Inst. 93: 1465–1472
Nguyen CT, Gonzales FA, Jones PA . 2001b Nucleic Acids Res. 29: 4598–4606
O'Neill RJ, Eldridge MD, Graves JA . 2001 Mamm. Genome 12: 256–259
O'Neill R, O'Neill M, Graves JA . 1998 Nature 393: 68–72
Okano M, Bell DW, Haber DA, Li E . 1999 Cell 98: 247–257
Oswald J, Engemann S, Lane N, Mayer W, Olek A, Fundele R, Dean W, Reik W, Walter J . 2000 Curr. Biol. 10: 475–478
Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ . 1995 Cancer Res. 55: 1894–1901
Poirier LA . 1994 Drug Metab. Rev. 26: 185–199
Qu G, Dubeau L, Narayan A, Yu M, Ehrlich M . 1999a Mut. Res. 423: 91–101
Qu G, Grundy PE, Narayan A, Ehrlich M . 1999b Cancer Genet. Cytogenet. 109: 34–39
Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R . 2000 Proc. Natl. Acad. Sci. USA 97: 5237–5242
Razin A, Kafri T . 1994 Prog. Nucleic Acids Res. Mol. Biol. 48: 53–81
Ribieras S, Song-Wang XG, Martin V, Lointier P, Frappart L, Dante R . 1994 J. Cell. Biochem. 56: 86–96
Robertson KD . 2000 Curr. Opin. Microbiol. Immunol. 249: 21–34
Rothberg PG, Ponnuru S, Baker D, Bradley JF, Freeman AI, Cibis GW, Harris DJ, Heruth DP . 1997 Mol. Carcinog. 19: 69–73
Rubin CM, VandeVoort CA, Teplitz RL, Schmid CW . 1994 Nucleic Acids Res. 22: 5121–5127
Sabbattini P, Lundgren M, Georgiou A, Chow C, Warnes G, Dillon N . 2001 EMBO J. 20: 2812–2822
Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . 2001 Hepatology 33: 561–568
Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA . 1999 Prostate 39: 166–174
Sasaki H, Ishihara K, Kato R . 2000 J. Biochem. (Tokyo) 127: 711–715
Sassaman DM, Dombroski BA, Moran JV, Kimberland ML, Naas TP, DeBerardinis RJ, Gabriel A, Swergold GD, Kazazian Jr HH . 1997 Nat. Genet. 16: 37–43
Schichman SA, Caligiuri MA, Strout MP, Carter SL, Gu Y, Canaani E, Bloomfield CD, Croce CM . 1994 Cancer Res. 54: 4277–4280
Schofield PN, Joyce JA, Lam WK, Grandjean V, Ferguson-Smith A, Reik W, Maher ER . 2001 Toxicol. Lett. 120: 151–160
Schwienbacher C, Gramantieri L, Scelfo R, Veronese A, Calin GA, Bolondi L, Croce CM, Barbanti-Brodano G, Negrini M . 2000 Proc. Natl. Acad. Sci. USA 97: 5445–5449
Serrano A, Garcia A, Abril E, Garrido F, Ruiz-Cabello F . 1996 Int. J. Cancer 68: 464–470
Sharrard RM, Royds JA, Rogers S, Shorthouse AJ . 1992 Br. J. Cancer 65: 667–672
Shen L, Fang J, Qiu D, Zhang T, Yang J, Chen S, Xiao S . 1998 Hepatogastroenterology 45: 1753–1759
Shiraishi M, Sekiguchi A, Chuu YH, Sekiya T . 1999 Biol. Chem. 380: 81–84
Smilinich NJ, Day CD, Fitzpatrick GV, Caldwell GM, Lossie AC, Cooper PR, Smallwood AC, Joyce JA, Schofield PN, Reik W, Nicholls RD, Weksberg R, Driscoll DJ, Maher ER, Shows TB, Higgins MJ . 1999 Proc. Natl. Acad. Sci. USA 96: 8064–8069
Smiraglia DJ, Rush LJ, Fruhwald MC, Dai Z, Held WA, Costello JF, Lang LC, Eng C, Li B, Wright FA, Caligiuri MA, Plass C . 2001 Hum. Mol. Genet. 10: 1413–1419
Soares J, Pinto AE, Cunha CV, Andre S, Barao I, Sousa JM, Cravo M . 1999 Cancer 85: 112–118
Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE . 1999 Oncogene 18: 7527–7534
Takacs M, Myohanen S, Altiok E, Minarovits J . 1998 Biol. Chem. 379: 417–422
Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA . 2001 Hum. Mol. Genet. 10: 2619–2626
Takai D, Yagi Y, Habib N, Sugimura T, Ushijima T . 2000 Jpn. J. Clin. Oncol. 30: 306–309
Tanaka Y, Fukudome K, Hayashi M, Takagi S, Yoshie O . 1995 Int. J. Cancer 60: 554–561
Tao L, Yang S, Xie M, Kramer PM, Pereira MA . 2000 Cancer Lett. 158: 185–193
Thomas GA, Williams ED . 1992 Carcinogenesis 13: 1039–1042
Thoraval D, Asakawa J, Kodaira M, Chang C, Radany E, Kuick R, Lamb B, Richardson B, Neel JV, Glover T, Hanash S . 1996a Proc. Natl. Acad. Sci. USA 93: 4442–4447
Thoraval D, Asakawa J, Wimmer K, Kuick R, Lamb B, Richardson B, Ambros P, Glover T, Hanash S . 1996b Genes Chromosomes Cancer 17: 234–244
Tuck-Muller CM, Narayan A, Tsien F, Smeets D, Sawyer J, Fiala ES, Sohn O, Ehrlich M . 2000 Cytogen. Cell. Genet. 89: 121–128
Tycko B . 2000 DNA and Alterations in Cancer: Genetic and Epigenetic Alterations Ehrlich M (ed) Natick: Eaton Publishing pp. 333–349
Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T, Nagao M . 1997 Proc. Natl. Acad. Sci. USA 94: 2284–2289
Wahlfors J, Hiltunen H, Heinonen K, Hamalainen E, Alhonen L, Janne J . 1992 Blood 80: 2074–2080
Walsh CP, Chaillet JR, Bestor TH . 1998 Nat. Genet. 20: 116–117
Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV . 2001 Clin. Cancer Res. 7: 1553–1560
Watt PM, Kumar R, Kees UR . 2000 Genes Chromosomes Cancer 29: 371–377
Wei W, Gilbert N, Ooi SL, Lawler JF, Ostertag EM, Kazazian HH, Boeke JD, Moran JV . 2001 Mol. Cell. Biol. 21: 1429–1439
Whitelaw E, Martin DI . 2001 Nat. Genet. 27: 361–365
Wong N, Lam WC, Lai PB, Pang E, Lau WY, Johnson PJ . 2001 Am. J. Pathol. 159: 465–471
Xu G, Bestor TH, Bourc'his D, Hsieh C, Tommerup N, Hulten M, Qu S, Russo JJ, Viegas-Péquignot E . 1999 Nature 402: 187–191
Yan PS, Rodriguez FJ, Laux DE, Perry MR, Standiford SB, Huang TH . 2000 Br. J. Cancer 82: 514–517
Yuan L, Shan J, De Risi D, Broome J, Lovecchio J, Gal D, Vinciguerra V, Xu HP . 1999 Cancer Res. 59: 3215–3221
Zhang X-Y, Loflin PT, Gehrke CW, Andrews PA, Ehrlich M . 1987 Nucleic Acids Res. 15: 9429–9449
Zhang XY, Wang RY, Ehrlich M . 1985 Nucleic Acids Res. 13: 4837–4851
Acknowledgements
This work was supported in part by NIH Grant CA81506. I thank Drs Karim Malik and Anthony Reeves for critical reading of the section on imprinted genes.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene 21, 5400–5413 (2002). https://doi.org/10.1038/sj.onc.1205651
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205651
Keywords
This article is cited by
-
Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
Scientific Reports (2024)
-
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs
Clinical Epigenetics (2023)
-
Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis
BMC Urology (2023)
-
Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature
Scientific Reports (2023)
-
capTEs enables locus-specific dissection of transcriptional outputs from reference and nonreference transposable elements
Communications Biology (2023)